The last word on AI in biopharma: smarter processes led by Genki-BOT

Published: 12-Mar-2026
Pharma 5.0

AI, predictive modelling and automation are reshaping biopharma operations, enabling faster decisions and more reliable, data-driven workflows, says Maja Pedersen, COO at FUJIFILM Biotechnologies

You need to be a subscriber to read this article.
Click here to find out more.

AI is becoming an essential tool in biopharma. It enables organisations to make better decisions, reduce risk and allows skilled teams to focus on higher-value work. When implemented thoughtfully, AI can improve accuracy, predict outcomes, and provide insights that guide decision-making throughout manufacturing, quality and operations.

The potential for AI is enormous for organisations such as ours and it can help teams to achieve faster outcomes without compromising safety or compliance requirements. Manufacturing Chemist's Emily Letton speaks to FUJIFILM Biotechnologies' Maja Pedersen to find out more.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Fujifilm Diosynth Biotechnologies
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Visual management brings data to life in pharmaceutical manufacturing

Read more
Centralising and visualising disparate manufacturing data into an AI-enhanced, real-time dashboard environment enables pharmaceutical facilities to turn complex information into actionable insights that strengthen quality, efficiency, collaboration and continuous improvement

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    AI might find the molecule, but delivery decides whether it becomes a medicine As the pharmaceutical industry scales AI-driven discovery at unprecedented speed, will the early integration of formulation and manufacturability determine which computationally promising molecules become deliverable medicines?
  2. ISOQAR among first UK bodies to gain UKAS accreditation for AI management standard UK certification body ISOQAR has secured UKAS accreditation for ISO/IEC 42001, offering manufacturers and other regulated industries independent assurance that their AI systems meet internationally recognised governance benchmarks
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Visual management brings data to life in pharmaceutical manufacturing Centralising and visualising disparate manufacturing data into an AI-enhanced, real-time dashboard environment enables pharmaceutical facilities to turn complex information into actionable insights that strengthen quality, efficiency, collaboration and continuous improvement
  4. MasterControl MasterControl is the only platform life science leaders trust for integrated quality, manufacturing, and asset management. Our comprehensive QMS, modern MES, and complete CMMS—supported by compliant AI and unified analytics—embed control into every facet of your organization, so you can deliver life-changing products with confidence
  5. Medical device manufacturer bridges the IT/OT gap Learn how a large pharmaceutical and medical device manufacturer secured their OT networks with SecureOT Platform

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Visual management brings data to life in pharmaceutical manufacturing

Centralising and visualising disparate manufacturing data into an AI-enhanced, real-time dashboard environment enables pharmaceutical facilities to turn complex information into actionable insights that strengthen quality, efficiency, collaboration and continuous improvement
Pharma 5.0

ISOQAR among first UK bodies to gain UKAS accreditation for AI management standard

UK certification body ISOQAR has secured UKAS accreditation for ISO/IEC 42001, offering manufacturers and other regulated industries independent assurance that their AI systems meet internationally recognised governance benchmarks
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

AI might find the molecule, but delivery decides whether it becomes a medicine

As the pharmaceutical industry scales AI-driven discovery at unprecedented speed, will the early integration of formulation and manufacturability determine which computationally promising molecules become deliverable medicines?
Pharma 5.0

Insilico Medicine and China Medical System expand AI drug discovery collaborations

Insilico Medicine and China Medical System Holdings have announced multiple AI-driven R&D collaborations in central nervous system and autoimmune diseases, aiming to accelerate candidate progression into the clinic
Pharma 5.0

New computational approaches could pave the way for safer medicines with fewer side effects

Advances in computational modelling and artificial intelligence are offering new ways to understand why medicines cause side effects and how to avoid them in future drug development
You need to be a subscriber to read this article.
Click here to find out more.
Pharma 5.0

Strong data foundations determine success in AI/ML

AI and machine learning are increasingly embedded across the chemical R&D lifecycle, from discovery to QA/QC, with their greatest value emerging when high-quality, standardised data enables adaptive modelling that supports scientific judgement
Digital

Medical device manufacturer bridges the IT/OT gap

Learn how a large pharmaceutical and medical device manufacturer secured their OT networks with SecureOT Platform
Subscribe now